Chronic inflammatory demyelinating polyneuropathy (CIDP) is the most common chronic immune-mediated inflammatory polyneuropathy. It is progressive or relapsing for at least two months, results in peripheral nerve demyelination, and responds to immunosuppressive therapies.
CIPS can be classified as either “typical” or “variants.” Typical CIDP is the most common form and is characterized by symmetric proximal and distal muscle weakness.